Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
Pozycja w akcjach #41524
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
Cena akcji
$0.05646911
Ostatnia synchronizacja: 2025-05-28
Kapitalizacja rynkowa
$17.31K
Zmiana (1 dzień)
-1.67%
Zmiana (1 rok)
0.00%
Kraj
US
Handel LungLife AI, Inc. (LLAI)

Kategoria

Historia stopy dywidendy dla LungLife AI, Inc. (LLAI)
Stopa dywidendy (TTM) dla LungLife AI, Inc. (symbol akcji: LLAI) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla LungLife AI, Inc. (LLAI) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji